nausea%20-and-%20vomiting%20in%20pregnancy
NAUSEA & VOMITING IN PREGNANCY
Nausea & vomiting in pregnancy (NVP), commonly known as "morning sickness", affects 50-90% of pregnant women.
In most women, the condition manifests between the 4th-7th week after last menstrual period and resolves by the 16th week of gestation.
It manifests in a spectrum of severity from mild nausea to very rare life-threatening symptoms.
The etiology is multifactorial.
The pregnant woman's sense of well-being and her daily activities are greatly affected by nausea and vomiting; the physical and emotional impact often leads to anxiety and worry about the effect of the symptoms on the fetus and reduced job efficiency.
Drug Information

Indication: Symptomatic relief of allergy or hypersensitivity reactions eg, hay fever, urticaria, angioedema, rhinitis, co...

Daneuron
vitamin B1 + vitamin B12 + vitamin B6

Indication: Neurological disorders & metabolic function disturbances including diabetic polyneuropathy, alcoholic peri...

Diprodin
diphenhydramine hydrochloride + ephedrine hydrochl...

Indication: Temporary relief of nasal & sinus congestion associated w/ wet cough, common cold & allergic rhinitis.

Florxine
folic acid + pyridoxine hydrochloride

Indication: Dietary supplement that helps restore pyridoxine & folic acid levels needed by the body for good health du...

Neurobion
cyanocobalamin + pyridoxine + thiamine

Indication: Neurological & other disorders associated w/ disturbances of metabolic functions influenced by vit B compl...

Neurorubine Forte
vitamin B1 + vitamin B12 + vitamin B6

Indication: Sciatica, lumbago, alcoholic neuritis, diabetic neuritis, trigeminal neuralgia, migraine, arthritis, CV diseas...

Indication: Nausea & vomiting induced by gastroduodenal disorders ie, flatulent dyspepsia, gastritis, gastroenteritis,...

Indication: Symptomatic treatment for upper resp tract & skin allergic conditions eg, allergic rhinitis, urticaria &am...

Indication: Prevention & treatment of vomiting due to irradiation-sickness, post-op & drug-induced nausea & vo...

Re-B Forte
cyanocobalamin + pyridoxine hydrochloride + thiami...

Indication: Neurological & other disorders associated w/ nerve cell metabolism disturbance where high-dose vit B-compl...

1  /  4
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS JPOG - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
18 Jun 2019
The aromatase inhibitor anastrozole shows promise in the treatment of children with congenital adrenal hyperplasia, reducing bone age advancement without adversely affecting bone mineral density and visceral adipose tissue, as shown in a recent study.
16 hours ago
Monotherapy with tenofovir disoproxil fumarate increases virologic response for up to 240 weeks in pretreated patients with hepatitis B virus infection (HBV) who are resistant to entecavir and/or adefovir, a new study has found.
Elvira Manzano, Yesterday
Long-term treatment with the interleukin-5 receptor alpha-directed cytolytic monoclonal antibody benralizumab led to long-term control of asthma, improvement in pulmonary function, and was safe in patients with severe eosinophilic asthma in the 2-year integrated analysis of the SIROCCO, CALIMA, and ZONDA pivotal studies plus the BORA extension study reported at ATS 2019.
Pearl Toh, Yesterday
Emerging evidence is showing that the two major new classes of antidiabetic drugs — SGLT2* inhibitors and GLP-1** receptor agonists (RAs) — not only confer cardiovascular (CV) benefits to patients with type 2 diabetes (T2D), they also delay the loss of kidney function among these patients, potentially providing nephrologists with an additional tool in their armamentarium for managing patients with chronic kidney disease (CKD) in the future.